Stefan Kernstock, CEO, SERO
Torsten Knüttel, VP Research and Development, Gentian Diagnostics
Mia Louise Kråkstad, Healthcare Director, IQVIA Nordics
Stefan Kernstock, CEO, SERO
Torsten Knüttel, VP Research and Development, Gentian Diagnostics
Mia Louise Kråkstad, Healthcare Director, IQVIA Nordics
Bjørn Liaset, CSO, Biomega Group
Silje Båtsvik Risholm, Senior Advisor, Bellona
Adrian Diaz, Chief Product Officer, Völur
Ingrid Dynna, CEO and co-founder of NoMy
Trond Atle Smedsrud, CEO Emerging Business, Aker BioMarine
Kristin Hollung, Research Director, Nofima
Olav Kjørven, Sustainability Advisor. Former CEO of EAT, Director of Public Partnerships at UNICEF and Special Advisor at UNDP
Kristin Hollung, Research Director, Nofima
Lene Frost Andersen, Head of Department Institute of Basic Medical Sciences, UiO
Hanne Haslene Hox, Senior Research Scientist, SINTEF
Guro Bjøntegaard, Country Director, AstraZenica
Liv Bjørnhaug Johansen, Senior Advisor, Norwegian Women’s Public Health Association
Else Charlotte Sandset, Chair of Stroke and General Neurology at OUS & Researcher at UiO
Fridtjof Lund-Johansen, Group Leader: Protein Array Group, Oslo University Hospital
Geir Kjetil Sandve, Professor in Scientific Computing and Machine Learning, University of Oslo
Herbert Altman, Service Area Head Europe, Market Access, Pricing & Reimbursement at Pharmalex, part of Cencora.
Geir Åge Løset, CEO at Nextera.
Roberto Spreafico, Senior Director, Discovery Data Science at Genmab
Fritjof Lund-Johannsen, Group Leader: Protein Array Group, Oslo University Hospital
Erik Wold, Investment Director, Investinor
Georgina Askeland, Principal, Hadean Ventures
Anders Kapstad, CFO and Life Cycle Manager, Inven2
With greeting from Anita Leirvik North, Vice Mayor for Culture and Business Development in Oslo